Calling for an annual FDA report on the RACE for Children Act PolicySteve WosahlaOctober 30, 2024RACE Act, drug development, new therapies
A Look Back at 2023: What We've Achieved Together ProgramsJessica KeanDecember 20, 2023Year in Review, legislation, survivors, drug development
International Pediatric Oncology Conference Highlights Role of Global Advocates AdvocacySteve WosahlaFebruary 24, 2023ACCELERATE, parent advocates, drug development, global, collaboration
First Two Years of the RACE Act Evaluated in New GAO Report PolicySteve WosahlaFebruary 8, 2023RACE Act, drug development, new therapies
Nausea, Taste, and Schedule Highlighted as Challenges in Survivor Focus Group on Medications ResearchJessica KeanApril 19, 2021drug development
FDA Approves Crizotinib for Treatment of Rare Lymphoma in Children ResearchJessica KeanJanuary 15, 2021FDA, drug development, XALKORI, lymphoma